These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10434801)

  • 21. [Discontinuation of beta blockers in patients with angina pectoris].
    Rangno RE
    Internist (Berl); 1983 Jan; 24(1):55-8. PubMed ID: 6132895
    [No Abstract]   [Full Text] [Related]  

  • 22. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    Baker JG
    Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug therapy of angina pectoris].
    Scrutinio D; Chiddo A; Mastrangelo D; Lagioia R; Rizzon P
    Cardiologia; 1985 Jan; 30 Suppl 1():1-93. PubMed ID: 2864136
    [No Abstract]   [Full Text] [Related]  

  • 24. Managing stable angina pectoris: nitroglycerin, beta blockers and risk factor reduction.
    Wright C
    Nurse Pract; 1984 Feb; 9(2):54, 55, 57 passim. PubMed ID: 6143290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Beta-blockers in effort angina].
    Witchitz S; Kolsky H; Moisson P; Philippe B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():87-95. PubMed ID: 6134513
    [No Abstract]   [Full Text] [Related]  

  • 26. Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.
    Kardas P
    Vasc Health Risk Manag; 2007; 3(2):235-42. PubMed ID: 17580734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1422-5. PubMed ID: 2903653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of angina pectoris--state of the art].
    Nager F
    Schweiz Rundsch Med Prax; 1990 Mar; 79(10):267-76. PubMed ID: 1969177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of nifedipine alone versus in combination with beta blockers and/or nitrates on left ventricular function in angina pectoris.
    Miller A
    Am J Cardiol; 1983 Nov; 52(8):1152. PubMed ID: 6139006
    [No Abstract]   [Full Text] [Related]  

  • 30. [Differential diagnosis with adrenergic beta blockers].
    Bodem G
    Fortschr Med; 1979 Aug; 97(30-31):1301-4. PubMed ID: 38195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological and therapeutic basis for combined administration of beta blockers and calcium channel blockers in the treatment of stable chronic angina.
    Spaulding C; Cabanes L; Weber S
    Br J Clin Pract Suppl; 1997 Apr; 88():17-22. PubMed ID: 9519503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris.
    Packer M
    N Engl J Med; 1989 Mar; 320(11):709-18. PubMed ID: 2564164
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug therapy of angina pectoris].
    Frick MH
    Duodecim; 1972; 88(21):1362-7. PubMed ID: 4144180
    [No Abstract]   [Full Text] [Related]  

  • 36. Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans.
    de Mey C; Breithaupt K; Schloos J; Neugebauer G; Palm D; Belz GG
    Clin Pharmacol Ther; 1994 Mar; 55(3):329-37. PubMed ID: 7908256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nifedipine therapy in angina pectoris: evaluation of safety and side effects.
    Terry RW
    Am Heart J; 1982 Sep; 104(3):681-9. PubMed ID: 6126114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
    Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Beta-blockaders and angina pectoris].
    Broustet JP; Emeriau JP; Conri C; Vallaud F; Clementy J
    Coeur Med Interne; 1978; 17(1):95-109. PubMed ID: 25162
    [No Abstract]   [Full Text] [Related]  

  • 40. Selection of optimal drug therapy for the patient with angina pectoris.
    Shub C; Vlietstra RE; McGoon MD
    Mayo Clin Proc; 1985 Aug; 60(8):539-48. PubMed ID: 2862309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.